Desirable L-asparaginases for treating cancer and current research trends

Desirable L-asparaginases for treating cancer and current research trends

Amino acid depletion therapy is a promising approach for cancer treatment. It exploits the differences in the metabolic processes between healthy and cancerous cells. Certain microbial enzymes induce cancer cell apoptosis by removing essential amino acids. L-asparaginase is an enzyme approved by the...

Full description

Bibliographic Details
Main Authors:	Kindu Tsegaye, Berhanu Andualem Tsehai, Birhan Getie
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Microbiology
Subjects:	acute lympho blastic leukemia cancer kinetic properties L-asparaginase Michaelis constant
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1269282/full

Similar Items

Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment
by: T. T. Valiev
Published: (2023-09-01)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
by: Luke Maese, et al.
Published: (2022-06-01)

Diverse origins of microbial L-asparaginases and their current miscellaneous applications
by: Nada A. Abdelrazek, et al.
Published: (2019-06-01)

Isolation and Screening of L-asparaginase Producing Strains from Nature and its Optimization
by: Gholam Reza Ghezelbash, et al.
Published: (2018-09-01)

Asparaginase-Induced Acute Necrotizing Pancreatitis Resulting in Chronic Pancreatitis and Pseudocyst in an Adult with Acute Lymphocytic Leukemia
by: Randy Adiwinata, et al.
Published: (2023-04-01)

Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol
by: Jian Wang, et al.
Published: (2023-12-01)

The Outcome of Children With Acute Lymphoblastic Leukemia Without Receiving Sufficient Dose of L-Asparaginase
by: Gholamreza Bahoush, et al.
Published: (2020-07-01)

Successful treatment of pancreatitis caused by L-asparaginase in clinical practice
by: Yu. S. Korkina, et al.
Published: (2024-01-01)

In-silico evaluation of fungal and bacterial L-asparaginases allergenicity
by: Tekeba Sisay, et al.
Published: (2023-01-01)

Production of Recombinant E.coli Asparaginase on a Laboratory Scale
by: Zahra Zeinali, et al.
Published: (2023-01-01)

Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen
by: Ibrahim Al Nabhani, et al.
Published: (2023-02-01)

Identification of L-asparaginases from Streptomyces strains with competitive activity and immunogenic profiles: a bioinformatic approach
by: Iván González-Torres, et al.
Published: (2020-11-01)

Encapsulation of Asparaginase as a Promising Strategy to Improve In Vivo Drug Performance
by: Francisca Villanueva-Flores, et al.
Published: (2021-11-01)

Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol
by: M. Yu. Goroshkova, et al.
Published: (2022-11-01)

Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences
by: Daiane Keller Cecconello, et al.
Published: (2024-08-01)

L-asparaginase: New about Well-Known Drug
by: Yuliya S. Korkina, et al.
Published: (2021-07-01)

Evaluating the Frequencies of CNOT3, GRIA1, NFATC2, and PNPLA3 Variant Alleles and Their Association with L-Asparaginase Hypersensitivity in Pediatric Acute Lymphoblastic Leukemia in Addis Ababa, Ethiopia
by: Ali AM, et al.
Published: (2023-08-01)

Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment
by: Carmelo Rizzari, et al.
Published: (2014-09-01)

Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine
by: Dominique Bollino, et al.
Published: (2022-12-01)

Peg-Grafted Liposomes for L-Asparaginase Encapsulation
by: Marina de Souza Guimarães, et al.
Published: (2022-08-01)

Reactions related to asparaginase infusion in a 10-year retrospective cohort
by: Amanda Cabral dos Santos, et al.

Peg-asparaginase associated toxicities in children with acute lymphoblastic leukemia: A single-center cross-sectional study
by: Sameh Awwad, et al.
Published: (2024-03-01)

Effects of Temperature, pH and Substrate Concentration on the Kinetics of Salivary Alpha- Amylase Activity among Cigarette Smokers in Awka, Anambra State, Nigeria.
by: B.N. Enemchukwu,, et al.
Published: (2013-05-01)

Follow our path with asparaginase activity: one technique, but different uses in clinical practice
by: Daiane Keller Cecconello, et al.
Published: (2022-11-01)

RETRACTED: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study
by: Yun-yu Zhang, et al.
Published: (2020-10-01)

Asparaginase activity monitoring in pediatric acute lymphoblastic leukemia: A cross‐sectional nationwide study in Spain
by: Álvaro Lassaletta, et al.
Published: (2023-02-01)

Requirement for ER-mitochondria Ca2+ transfer, ROS production and mPTP formation in L-asparaginase-induced apoptosis of acute lymphoblastic leukemia cells
by: Jung Kwon Lee, et al.
Published: (2023-02-01)

Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia
by: Ashkan Emadi, et al.
Published: (2016-03-01)

Isolation and Characterization of Glutaminase-free L-asparaginase Produced by Staphylococcus sp. MGM1
by: Gholamhossein Ebrahimipour, et al.
Published: (2020-06-01)

Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
by: Soulaimane M'harzi, et al.
Published: (2022-01-01)

Cloning and molecular analysis of L-asparaginase II gene (ansB)
by: ZEINAT K. MOHAMED, et al.
Published: (2015-12-01)

Acquired Clotting Factor Deficits During Treatment with Asparaginase in an Institutional Cohort
by: Papadopoulou V, et al.
Published: (2023-11-01)

Isolation and Purification of L-Asparaginase from Persian Gulf Streptomyces Isolates and Evaluation of It’s Cloned Gene Expression in Escherichia Coli by Real-Time and SDS-PAGE
by: Hadiseh Soofer, et al.
Published: (2020-08-01)

A Comparative Study on Pseudomonal and Bacillus L. asparaginases
by: Nuzhath Fatima, et al.
Published: (2019-09-01)

Expert recommendations for pancreatitis/pancreatic necrosis treatment after L-asparaginase in children with acute lymphoblastic leukemia
by: T. T. Valiev, et al.
Published: (2024-04-01)

L‐asparaginase doses number as a prognostic factor in childhood acute lymphoblastic leukemia: A survival analysis study
by: Amanda Cabral dosSantos, et al.
Published: (2022-08-01)

Hypertriglyceridemia with pancreatitis, a complication of l-asparaginase therapy in acute lymphoblastic leukemia, managed by therapeutic plasma exchange
by: Sourav Chowdhury, et al.
Published: (2023-01-01)

Differential impact of asparaginase discontinuation on outcomes of children with T‐cell acute lymphoblastic leukemia and T‐cell lymphoblastic lymphoma
by: Hisashi Ishida, et al.
Published: (2024-06-01)

Preclinical evaluation of engineered L-asparaginase variants to improve the treatment of Acute Lymphoblastic Leukemia
by: Soumika Sengupta, et al.
Published: (2024-05-01)

Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles
by: Larissa Pereira Brumano, et al.
Published: (2019-01-01)